10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0000950170-22-023288 |
| Period End Date | 20220930 |
| Filing Date | 20221108 |
| Fiscal Year | 2022 |
| Fiscal Period | Q3 |
| XBRL Instance | talk-20220930_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
60 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Allowance, Accounts Receivable |
AllowanceForDoubtfulAccountsReceivable
|
$3.29M | USD | Point-in-time |
| Allowance, Accounts Receivable |
AllowanceForDoubtfulAccountsReceivable
|
$4.92M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$152.64M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$198.26M | USD | Point-in-time |
| Accounts receivable, net of reserves of $3,294 and $4,918 as of September 30, 2022 and December 31, 2021, respectively |
AccountsReceivableNetCurrent
|
$8.69M | USD | Point-in-time |
| Common stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Accounts receivable, net of reserves of $3,294 and $4,918 as of September 30, 2022 and December 31, 2021, respectively |
AccountsReceivableNetCurrent
|
$5.51M | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
1.00B | shares | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$4.61M | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
1.00B | shares | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$9.56M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$165.94M | USD | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
152.86M | shares | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
158.99M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$213.33M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$845.00K | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$624.00K | USD | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
152.86M | shares | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
158.99M | shares | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$3.44M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$2.71M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$6.13M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$6.13M | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
- | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$82.00K | USD | Point-in-time |
| Total assets |
Assets
|
$223.61M | USD | Point-in-time |
| Total assets |
Assets
|
$175.63M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$10.36M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$7.43M | USD | Point-in-time |
| Deferred revenues |
ContractWithCustomerLiabilityCurrent
|
$7.19M | USD | Point-in-time |
| Deferred revenues |
ContractWithCustomerLiabilityCurrent
|
$5.46M | USD | Point-in-time |
| Accrued expenses and other current liabilities |
AccruedLiabilitiesAndOtherLiabilitiesCurrent
|
$12.56M | USD | Point-in-time |
| Accrued expenses and other current liabilities |
AccruedLiabilitiesAndOtherLiabilitiesCurrent
|
$13.21M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$29.02M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$27.18M | USD | Point-in-time |
| Warrant liabilities |
WarrantLiabilitiesNonCurrent
|
$4.07M | USD | Point-in-time |
| Warrant liabilities |
WarrantLiabilitiesNonCurrent
|
$3.65M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$288.00K | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$86.00K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$31.33M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$32.96M | USD | Point-in-time |
| Commitments and contingencies (Note 5) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 5) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock of $0.0001 par value - Authorized: 1,000,000,000 shares at September 30, 2022 and December 31, 2021; Issued and outstanding: 158,991,019 and 152,862,447 shares at September 30, 2022 and December 31, 2021, respectively |
CommonStockValue
|
$15.00K | USD | Point-in-time |
| Common stock of $0.0001 par value - Authorized: 1,000,000,000 shares at September 30, 2022 and December 31, 2021; Issued and outstanding: 158,991,019 and 152,862,447 shares at September 30, 2022 and December 31, 2021, respectively |
CommonStockValue
|
$15.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$363.79M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$375.55M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-232.90M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-171.53M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$176.28M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$-98.90M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$-109.20M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$157.25M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$206.88M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$192.27M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$202.26M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$142.67M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$175.63M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$223.61M | USD | Point-in-time |
Income Statement
72 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$89.33M | USD | 3 Qtrs |
| Revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$84.50M | USD | 3 Qtrs |
| Revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$29.33M | USD | 1 Quarter |
| Revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$26.36M | USD | 1 Quarter |
| Cost of revenues |
CostOfRevenue
|
$33.70M | USD | 3 Qtrs |
| Cost of revenues |
CostOfRevenue
|
$45.16M | USD | 3 Qtrs |
| Cost of revenues |
CostOfRevenue
|
$14.74M | USD | 1 Quarter |
| Cost of revenues |
CostOfRevenue
|
$12.19M | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$50.80M | USD | 3 Qtrs |
| Gross profit |
GrossProfit
|
$14.17M | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$14.60M | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$44.16M | USD | 3 Qtrs |
| Research and development, net |
ResearchAndDevelopmentExpense
|
$6.18M | USD | 1 Quarter |
| Research and development, net |
ResearchAndDevelopmentExpense
|
$12.02M | USD | 3 Qtrs |
| Research and development, net |
ResearchAndDevelopmentExpense
|
$4.28M | USD | 1 Quarter |
| Research and development, net |
ResearchAndDevelopmentExpense
|
$16.79M | USD | 3 Qtrs |
| Clinical operations |
OtherCostAndExpenseOperating
|
$2.22M | USD | 1 Quarter |
| Clinical operations |
OtherCostAndExpenseOperating
|
$1.90M | USD | 1 Quarter |
| Clinical operations |
OtherCostAndExpenseOperating
|
$5.89M | USD | 3 Qtrs |
| Clinical operations |
OtherCostAndExpenseOperating
|
$6.31M | USD | 3 Qtrs |
| Sales and marketing |
SellingAndMarketingExpense
|
$75.12M | USD | 3 Qtrs |
| Sales and marketing |
SellingAndMarketingExpense
|
$18.38M | USD | 1 Quarter |
| Sales and marketing |
SellingAndMarketingExpense
|
$58.71M | USD | 3 Qtrs |
| Sales and marketing |
SellingAndMarketingExpense
|
$26.43M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$23.11M | USD | 3 Qtrs |
| General and administrative |
GeneralAndAdministrativeExpense
|
$6.79M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$7.67M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$24.47M | USD | 3 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$39.40M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$106.29M | USD | 3 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$34.45M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$116.15M | USD | 3 Qtrs |
| Operating (loss) |
OperatingIncomeLoss
|
$19.85M | USD | 1 Quarter |
| Operating (loss) |
OperatingIncomeLoss
|
$65.34M | USD | 3 Qtrs |
| Operating (loss) |
OperatingIncomeLoss
|
$62.13M | USD | 3 Qtrs |
| Operating (loss) |
OperatingIncomeLoss
|
$25.23M | USD | 1 Quarter |
| Financial income, net |
InterestAndDebtExpenseIncome
|
$26.74M | USD | 1 Quarter |
| Financial income, net |
InterestAndDebtExpenseIncome
|
$889.00K | USD | 3 Qtrs |
| Financial income, net |
InterestAndDebtExpenseIncome
|
$23.70M | USD | 3 Qtrs |
| Financial income, net |
InterestAndDebtExpenseIncome
|
$1.89M | USD | 1 Quarter |
| (Loss) income before taxes on income |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$61.24M | USD | 3 Qtrs |
| (Loss) income before taxes on income |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$41.65M | USD | 3 Qtrs |
| (Loss) income before taxes on income |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$17.97M | USD | 1 Quarter |
| (Loss) income before taxes on income |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$-1.52M | USD | 1 Quarter |
| Taxes on income |
IncomeTaxExpenseBenefit
|
$11.00K | USD | 1 Quarter |
| Taxes on income |
IncomeTaxExpenseBenefit
|
$127.00K | USD | 3 Qtrs |
| Taxes on income |
IncomeTaxExpenseBenefit
|
$29.00K | USD | 3 Qtrs |
| Taxes on income |
IncomeTaxExpenseBenefit
|
$17.00K | USD | 1 Quarter |
| Net (loss) income |
NetIncomeLoss
|
$1.50M | USD | 1 Quarter |
| Net (loss) income |
NetIncomeLoss
|
$-30.44M | USD | 1 Quarter |
| Net (loss) income |
NetIncomeLoss
|
$-12.74M | USD | 1 Quarter |
| Net (loss) income |
NetIncomeLoss
|
$-41.67M | USD | 3 Qtrs |
| Net (loss) income |
NetIncomeLoss
|
$-23.02M | USD | 1 Quarter |
| Net (loss) income |
NetIncomeLoss
|
$-61.37M | USD | 3 Qtrs |
| Net (loss) income |
NetIncomeLoss
|
$-17.98M | USD | 1 Quarter |
| Net (loss) income |
NetIncomeLoss
|
$-20.36M | USD | 1 Quarter |
| Basic |
EarningsPerShareBasic
|
$-0.39 | USD | 3 Qtrs |
| Basic |
EarningsPerShareBasic
|
$-0.64 | USD | 3 Qtrs |
| Basic |
EarningsPerShareBasic
|
$0.01 | USD | 1 Quarter |
| Basic |
EarningsPerShareBasic
|
$-0.11 | USD | 1 Quarter |
| Diluted |
EarningsPerShareDiluted
|
$-0.64 | USD | 3 Qtrs |
| Diluted |
EarningsPerShareDiluted
|
$-0.11 | USD | 1 Quarter |
| Diluted |
EarningsPerShareDiluted
|
$-0.39 | USD | 3 Qtrs |
| Diluted |
EarningsPerShareDiluted
|
$0.01 | USD | 1 Quarter |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
156.06M | shares | 3 Qtrs |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
64.64M | shares | 3 Qtrs |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
158.33M | shares | 1 Quarter |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
152.27M | shares | 1 Quarter |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
156.06M | shares | 3 Qtrs |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
158.33M | shares | 1 Quarter |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
165.18M | shares | 1 Quarter |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
64.64M | shares | 3 Qtrs |
Cash Flow Statement
63 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
NetIncomeLoss
|
$1.50M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-30.44M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-12.74M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-41.67M | USD | 3 Qtrs |
| Net loss |
NetIncomeLoss
|
$-23.02M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-61.37M | USD | 3 Qtrs |
| Net loss |
NetIncomeLoss
|
$-17.98M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-20.36M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.46M | USD | 3 Qtrs |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.01M | USD | 3 Qtrs |
| Amortization of debt issuance cost |
AmortizationOfFinancingCosts
|
$175.00K | USD | 3 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$20.58M | USD | 3 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$9.39M | USD | 3 Qtrs |
| Warrant change in fair value |
WarrantIssuanceCostAndChangeInFairValue
|
$23.84M | USD | 3 Qtrs |
| Warrant change in fair value |
WarrantIssuanceCostAndChangeInFairValue
|
$421.00K | USD | 3 Qtrs |
| (Increase) decrease in accounts receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$-596.00K | USD | 3 Qtrs |
| (Increase) decrease in accounts receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$3.18M | USD | 3 Qtrs |
| Decrease (increase) in other current assets |
IncreaseDecreaseInOtherCurrentAssets
|
$-4.85M | USD | 3 Qtrs |
| Decrease (increase) in other current assets |
IncreaseDecreaseInOtherCurrentAssets
|
$8.52M | USD | 3 Qtrs |
| Increase in accounts payable |
IncreaseDecreaseInAccountsPayable
|
$2.93M | USD | 3 Qtrs |
| Increase in accounts payable |
IncreaseDecreaseInAccountsPayable
|
$7.11M | USD | 3 Qtrs |
| (Decrease) increase in deferred revenues |
IncreaseDecreaseInDeferredCharges
|
$-3.13M | USD | 3 Qtrs |
| (Decrease) increase in deferred revenues |
IncreaseDecreaseInDeferredCharges
|
$1.73M | USD | 3 Qtrs |
| Increase (decrease) in accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$-134.00K | USD | 3 Qtrs |
| Increase (decrease) in accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$1.47M | USD | 3 Qtrs |
| Increase in other long-term liabilities |
IncreaseDecreaseInOtherNoncurrentLiabilities
|
$202.00K | USD | 3 Qtrs |
| Increase in other long-term liabilities |
IncreaseDecreaseInOtherNoncurrentLiabilities
|
- | USD | 3 Qtrs |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-41.11M | USD | 3 Qtrs |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-46.86M | USD | 3 Qtrs |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$622.00K | USD | 3 Qtrs |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$254.00K | USD | 3 Qtrs |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-254.00K | USD | 3 Qtrs |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-622.00K | USD | 3 Qtrs |
| (Payments) proceeds from reverse capitalization, net of transaction costs |
ProceedsFromReverseCapitalizationNetOfTransactionCosts
|
$-645.00K | USD | 3 Qtrs |
| (Payments) proceeds from reverse capitalization, net of transaction costs |
ProceedsFromReverseCapitalizationNetOfTransactionCosts
|
$249.43M | USD | 3 Qtrs |
| Proceeds from borrowings |
ProceedsFromIssuanceOfDebt
|
$6.00M | USD | 3 Qtrs |
| Proceeds from borrowings |
ProceedsFromIssuanceOfDebt
|
- | USD | 3 Qtrs |
| Repayment of borrowings |
RepaymentsOfDebt
|
- | USD | 3 Qtrs |
| Repayment of borrowings |
RepaymentsOfDebt
|
$6.00M | USD | 3 Qtrs |
| Payment of debt issuance costs |
PaymentOfDeferredIssuanceCosts
|
$50.00K | USD | 3 Qtrs |
| Payment of debt issuance costs |
PaymentOfDeferredIssuanceCosts
|
- | USD | 3 Qtrs |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$2.70M | USD | 3 Qtrs |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$1.97M | USD | 3 Qtrs |
| Payments for employee taxes withheld related to vested stock-based awards |
PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested
|
- | USD | 3 Qtrs |
| Payments for employee taxes withheld related to vested stock-based awards |
PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested
|
$558.00K | USD | 3 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$251.35M | USD | 3 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$1.49M | USD | 3 Qtrs |
| Net (decrease) increase in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$209.62M | USD | 3 Qtrs |
| Net (decrease) increase in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-45.62M | USD | 3 Qtrs |
| Cash and cash equivalents at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$222.87M | USD | Point-in-time |
| Cash and cash equivalents at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$198.26M | USD | Point-in-time |
| Cash and cash equivalents at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$13.25M | USD | Point-in-time |
| Cash and cash equivalents at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$152.64M | USD | Point-in-time |
| Cash and cash equivalents at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$222.87M | USD | Point-in-time |
| Cash and cash equivalents at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$198.26M | USD | Point-in-time |
| Cash and cash equivalents at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$13.25M | USD | Point-in-time |
| Cash and cash equivalents at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$152.64M | USD | Point-in-time |
| Cash paid during the period for interest |
InterestPaidNet
|
$46.00K | USD | 3 Qtrs |
| Cash paid during the period for interest |
InterestPaidNet
|
$115.00K | USD | 3 Qtrs |
| Cash paid during the period for income taxes |
IncomeTaxesPaidNet
|
$122.00K | USD | 3 Qtrs |
| Cash paid during the period for income taxes |
IncomeTaxesPaidNet
|
- | USD | 3 Qtrs |
| Conversion of preferred stock to common stock |
ConversionOfStockAmountConverted1
|
$111.28M | USD | 3 Qtrs |
| Conversion of preferred stock to common stock |
ConversionOfStockAmountConverted1
|
- | USD | 3 Qtrs |
Stockholders Equity
49 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Beginning balance, value |
StockholdersEquity
|
$176.28M | USD | Point-in-time |
| Beginning balance, value |
StockholdersEquity
|
$-98.90M | USD | Point-in-time |
| Beginning balance, value |
StockholdersEquity
|
$-109.20M | USD | Point-in-time |
| Beginning balance, value |
StockholdersEquity
|
$157.25M | USD | Point-in-time |
| Beginning balance, value |
StockholdersEquity
|
$206.88M | USD | Point-in-time |
| Beginning balance, value |
StockholdersEquity
|
$192.27M | USD | Point-in-time |
| Beginning balance, value |
StockholdersEquity
|
$202.26M | USD | Point-in-time |
| Beginning balance, value |
StockholdersEquity
|
$142.67M | USD | Point-in-time |
| Beginning balance, shares |
CommonStockSharesOutstanding
|
152.86M | shares | Point-in-time |
| Beginning balance, shares |
CommonStockSharesOutstanding
|
158.99M | shares | Point-in-time |
| Common stock issued related to exercise of warrants, value |
StockIssuedDuringPeriodValueWarrants
|
$609.00K | USD | 1 Quarter |
| Acquisition of warrants, Amount |
StockIssuedDuringPeriodValueAcquisitions
|
$27.95M | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$286.00K | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$1.13M | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$797.00K | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$347.00K | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$2.06M | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$45.00K | USD | 1 Quarter |
| Restricted Stock Units Vested |
RestrictedStockUnitsVested
|
$-67.00K | USD | 1 Quarter |
| Restricted Stock Units Vested |
RestrictedStockUnitsVested
|
$-128.00K | USD | 1 Quarter |
| Restricted Stock Units Vested |
RestrictedStockUnitsVested
|
$-126.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$1.51M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$15.20M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$3.18M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$3.88M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$3.84M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$2.37M | USD | 1 Quarter |
| Preferred stock conversion, Value |
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
$111.28M | USD | 1 Quarter |
| Issuance of common stock in connection with Business Combination and PIPE offering, net of issuance costs, Amount |
IssuanceOfCommonStockInConnectionWithBusinessCombinationAndPipeOfferingNetOfIssuanceCostsAmount
|
$-803.00K | USD | 1 Quarter |
| Issuance of common stock in connection with Business Combination and PIPE offering, net of issuance costs, Amount |
IssuanceOfCommonStockInConnectionWithBusinessCombinationAndPipeOfferingNetOfIssuanceCostsAmount
|
$185.74M | USD | 1 Quarter |
| Issuance of warrants |
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
$125.00K | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$1.50M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-30.44M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-12.74M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-41.67M | USD | 3 Qtrs |
| Net loss |
NetIncomeLoss
|
$-23.02M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-61.37M | USD | 3 Qtrs |
| Net loss |
NetIncomeLoss
|
$-17.98M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-20.36M | USD | 1 Quarter |
| Ending balance, value |
StockholdersEquity
|
$176.28M | USD | Point-in-time |
| Ending balance, value |
StockholdersEquity
|
$-98.90M | USD | Point-in-time |
| Ending balance, value |
StockholdersEquity
|
$-109.20M | USD | Point-in-time |
| Ending balance, value |
StockholdersEquity
|
$157.25M | USD | Point-in-time |
| Ending balance, value |
StockholdersEquity
|
$206.88M | USD | Point-in-time |
| Ending balance, value |
StockholdersEquity
|
$192.27M | USD | Point-in-time |
| Ending balance, value |
StockholdersEquity
|
$202.26M | USD | Point-in-time |
| Ending balance, value |
StockholdersEquity
|
$142.67M | USD | Point-in-time |
| Ending balance, shares |
CommonStockSharesOutstanding
|
152.86M | shares | Point-in-time |
| Ending balance, shares |
CommonStockSharesOutstanding
|
158.99M | shares | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.